Celera Genomics Appoints Chief Operating Officer; Peter Chambre, CEO of Bespak plc to Lead Operations.Business Editors/Health & Medical Writers ROCKVILLE, Md.--(BW HealthWire)--July 3, 2000 Celera Genomics (NYSE NYSE See: New York Stock Exchange :CRA See Community Reinvestment Act. ), a PE Corporation business, announced today that Peter Chambre has been appointed chief operating officer Chief Operating Officer (COO) The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president. . "It is time for Celera to evolve into the second phase of its development," said J. Craig Venter  The introduction of this article is too short.To comply with Wikipedia's lead section guidelines, it should be expanded. , Ph.D., Celera's president and chief scientific officer. "Our achievements to date provide a solid platform for business growth requiring strong operational leadership. Peter Chambre brings that kind of track record to Celera." For the past six years, Mr. Chambre has been chief executive of Bespak plc, a market-leading drug delivery group based in the United Kingdom and listed on the London Stock Exchange London Stock Exchange London marketplace for securities. It was formed in 1773 by a group of stockbrokers who had been doing business informally in local coffeehouses. . He also has held senior management positions with Caradon plc and Bain & Company. "Peter Chambre brings a valuable combination of strategic vision and business acumen to Celera," noted Tony L. White, chairman, president and chief executive officer of PE Corporation. "His strategic vision, understanding of the market and focus on customer needs are important attributes at this stage of Celera's growth. Peter is uniquely qualified to provide the leadership essential to develop Celera's business initiatives for future growth and success. His broad experience in developing businesses should enable us to provide innovative solutions to our customers." PE Corporation comprises two operating groups. The Celera Genomics Group, headquartered in Rockville, MD, intends to become the definitive source of genomic and related medical information. The PE Biosystems Group (NYSE:PEB PEB Physical Evaluation Board PEB Presidential Emergency Board PEB Post Exposure Bake PEB Professional Engineers Board (Singapore) PEB Pre-Engineered Building PEB Personal Electronic Ballot PEB Performance Evaluation Board ), with sales of $1.2 billion during fiscal 1999, develops and markets instrument-based systems, reagents, software, and contract services to the life science industry and research community. PE Biosystems is headquartered in Foster City, CA, and comprises four divisions: Applied Biosystems Applied Biosystems, Inc. (formerly NASDAQ: ABIO) is the original name of a pioneer biotechnology company founded in 1981 in Foster City, California, among the Silicon Valley cities of the southern San Francisco Bay Area. , PE Informatics, PerSeptive Biosystems, and Tropix. Information about PE Corporation, including reports and other information filed by the company with the Securities and Exchange Commission, is available on the world wide web at www.pecorporation.com or by phoning 800/762-6923. Note to Editors: Celera, Celera Genomics, and PE Biosystems are trademarks of PE Corporation. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion